MARKET

ICUCW

ICUCW

SeaStar Medical
NASDAQ
0.0280
0.0000
0.00%
Closed 09:30 03/27 EDT
OPEN
0.0280
PREV CLOSE
0.0280
HIGH
0.0280
LOW
0.0280
VOLUME
186
TURNOVER
--
52 WEEK HIGH
0.0549
52 WEEK LOW
0.0084
MARKET CAP
--
P/E (TTM)
-0.0048
1D
5D
1M
3M
1Y
5Y
1D
SeaStar Medical's Q4 revenue rises, net loss narrows
Reuters · 4d ago
SeaStar Medical FY2025 operating loss narrows 31.76% to $12.2 million; revenue jumps 8.14x to $1.2 million
Reuters · 4d ago
Weekly Report: what happened at ICUCW last week (0316-0320)?
Weekly Report · 6d ago
SeaStar Medical Holding Corporation to report fourth-quarter and year-end 2025 results and host webcast call
Reuters · 03/18 20:08
Weekly Report: what happened at ICUCW last week (0309-0313)?
Weekly Report · 03/16 09:11
Weekly Report: what happened at ICUCW last week (0302-0306)?
Weekly Report · 03/09 09:11
SeaStar Medical Completes FDA-Mandated Enrollment for QUELIMMUNE Pediatric AKI Safety Registry
Reuters · 03/05 13:20
SEASTAR MEDICAL ANNOUNCES COMPLETION OF FDA ENROLLMENT REQUIREMENT FOR SAVE SURVEILLANCE REGISTRY EVALUATING QUELIMMUNE SAFETY FOR PEDIATRIC AKI
Reuters · 03/05 13:20
More
About ICUCW
SeaStar Medical Holding Corporation is a commercial-stage medical technology company. The Company is focused on developing extracorporeal therapies to reduce the consequences of hyperinflammation on vital organs. The Company's technologies rely on science to provide life-saving solutions to critically ill patients. The Company develops and commercializes cell-directed extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company uses its Selective Cytopheretic Device (SCD) technology platform to clinically validate several acute organ injury indications, including kidneys and lungs. Its investigational SCD is an extracorporeal synthetic membrane device designed to integrate into existing continuous renal replacement therapy (CRRT) systems that are commonly installed in hospitals throughout the United States.

Webull offers SeaStar Medical Holding Corp stock information, including NASDAQ: ICUCW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICUCW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ICUCW stock methods without spending real money on the virtual paper trading platform.